| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71335-0071-2 | 71335-0071 | HUMAN PRESCRIPTION DRUG | Irbesartan | Irbesartan | TABLET | ORAL | 20211227 | N/A | ANDA | ANDA203071 | Bryant Ranch Prepack | IRBESARTAN | 300 mg/1 | 90 TABLET in 1 BOTTLE (71335-0071-2) |
| 71335-0071-3 | 71335-0071 | HUMAN PRESCRIPTION DRUG | Irbesartan | Irbesartan | TABLET | ORAL | 20211227 | N/A | ANDA | ANDA203071 | Bryant Ranch Prepack | IRBESARTAN | 300 mg/1 | 28 TABLET in 1 BOTTLE (71335-0071-3) |
| 71335-0071-4 | 71335-0071 | HUMAN PRESCRIPTION DRUG | Irbesartan | Irbesartan | TABLET | ORAL | 20211227 | N/A | ANDA | ANDA203071 | Bryant Ranch Prepack | IRBESARTAN | 300 mg/1 | 60 TABLET in 1 BOTTLE (71335-0071-4) |
| 71335-2168-1 | 71335-2168 | HUMAN PRESCRIPTION DRUG | Irbesartan | Irbesartan | TABLET | ORAL | 20220906 | N/A | ANDA | ANDA203071 | Bryant Ranch Prepack | IRBESARTAN | 150 mg/1 | 30 TABLET in 1 BOTTLE (71335-2168-1) |
| 71335-2745-1 | 71335-2745 | HUMAN PRESCRIPTION DRUG | Irbesartan | Irbesartan | TABLET | ORAL | 20251002 | N/A | ANDA | ANDA203071 | Bryant Ranch Prepack | IRBESARTAN | 75 mg/1 | 30 TABLET in 1 BOTTLE (71335-2745-1) |
| 71335-2745-2 | 71335-2745 | HUMAN PRESCRIPTION DRUG | Irbesartan | Irbesartan | TABLET | ORAL | 20251002 | N/A | ANDA | ANDA203071 | Bryant Ranch Prepack | IRBESARTAN | 75 mg/1 | 90 TABLET in 1 BOTTLE (71335-2745-2) |